Detecting Fraud and Misconduct in Clinical Trials: 2-day In-Person Seminar
Tuesday, February 4, 2014 at 8:30 AM - Wednesday, February 5, 2014 at 4:30 PM (PST)
Salt Lake City, UT
This course on detecting clinical trial fraud provides a solid understanding of GCP requirements and clinical quality assurance in detecting misconduct in clinical research. Attendees will gain experience in detecting, correcting and preventing clinical study misconduct and fraud at domestic and international clinical sites. It is important to understand the differences between lack of knowledge and poor execution vs. actual misconduct and fraud. This course will discuss some of the common issues seen in clinical trials, how to handle problem findings and how to distinguish between poor performance and misconduct.
Attendees will learn how to ensure that their study conduct and supporting documentation is accurate and factual. The course will also address how to uncover misconduct as well as deal with its consequences, while identifying proactive solutions to prevent further problems. Included in the course work are practical examples and a roadmap for evaluating study conduct, source documents, case report forms and other study documentation through presentation and interactive case studies.
Additionally, the course will cover methods to detect misconduct and deal with fraud in clinical trials by:
- Defining the basic requirements of Good Clinical Practices.
- Determining the appropriate duties and oversight required of the sponsor, monitor and investigators to ensure a high level of quality in a clinical trial.
- Ensuring that quality practices are designed and implemented to guarantee compliant clinical trials.
- Learning how to effectively manage a Sponsor as well as an FDA GCP inspection.
- Developing mechanisms to uncover and preclude fraud and misconduct in clinical trials.
- Building trial guidelines/structure which will easily identify any misconduct and which is capable of quickly addressing any issues that arise in order to avoid regulatory consequences.
Case study analysis, exercises and videos will be used throughout the course to provide insight and promote discussion.
Upon completion, attendees will be able to:
- Define the basic roles and responsibilities of the sponsor, monitor, investigators and FDA as they relate to the quality of clinical trials.
- Understand the GCP audit process for sponsors.
- Know when to conduct audits of vendors, sites, IRBs and laboratories.
- Respond to an audit to avoid further regulatory consequences.
- Learn how to detect and prevent fraud and misconduct in clinical trials.
- Understand telltale signs which may indicate fraud and/or misconduct.
- Fully understand, through the use of examples, the consequences which result when proper procedures are not followed.
Who Will Benefit:
This course will benefit those involved in the monitoring and/or QA of clinical trials. Individuals who work for pharmaceutical firms, medical device companies, Contract Research Organizations (CRO), Institutional Review Boards (IRBs), and academic institutions involved with the supervision or oversight of clinical trial practices and quality will find this course to be highly beneficial. The following titles will benefit:
- Clinical Research Associates
- Project Managers
- Clinical Investigators
- Study Coordinators
- IRB Professionals
- Clinical Quality Assurance Professionals
- Data Management Professionals
- Regulatory Affairs Professionals
When & Where
At ComplianceOnline, we are focused on :
- Enhancing global compliance, creating a world where quality and compliance professionals, regulators, and government agencies come together to help the world comply with the intent and the spirit of laws, policies and mandates, ensuring continuous improvement in global operations, quality & safety.
- Making sure that we are responsible corporate citizens helping our constituents build a more responsible enterprise, one which operates with high quality , under a code of ethics, and with process discipline to ensure greater shareholder returns.
- Keeping things simple and straight forward , so that we all can indeed improve the quality of our processes, our work, our businesses and enhance compliance globally.
- Being inclusive, giving the process experts ( & novices! ), compliance professionals, quality champions, and regulatory agencies a voice so that all of us can contribute and make a difference.